Search Results for: Release

Oral prolonged-release ketamine in treatment-resistant depression – A double-blind randomized placebo-controlled multicentre trial of KET01, a novel ketamine formulation – Clinical and safety results.

Oral prolonged-release ketamine in treatment-resistant depression – A double-blind randomized placebo-controlled multicentre trial of KET01, a novel ketamine formulation – Clinical and safety results.

Coronavirus Literature
Publication date: May 01, 2024 We investigated the antidepressant effects of a novel oral prolonged-release formulation of racemic ketamine (KET01) in patients suffering from treatment-resistant depression (TRD) as add-on therapy. ... Read more